ECLUNG consensus/guidelines development principles and methods (2024 edition)
Authors:
- Chunwei XuCXChunwei Xu
- Yue HaoYHYue Hao
- Dong WangDWDong Wang
- Shirong ZhangSZShirong Zhang
- Wenxian WangWWWenxian Wang
- Qian WangQWQian Wang
- Tangfeng LvTLTangfeng Lv
- Zhengbo SongZSZhengbo Song
- Ziming LiZLZiming Li
Open Access
- 1 April 2025
- journal article
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 3 (2) , 141-142
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid TumorsGlobal Medical Genetics, 2024
- Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in ChinaCancer, 2024
- Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid TumorsGlobal Medical Genetics, 2024
- Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in ChinaThoracic Cancer, 2023
- Chinese expert consensus on the diagnosis and treatment of malignant pleural mesotheliomaThoracic Cancer, 2023
- Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumorsThoracic Cancer, 2023
- Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancerThoracic Cancer, 2022
- Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitorThoracic Cancer, 2022
- Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in ChinaThoracic Cancer, 2022